EP0228539B1 - Protection apparatus for patient-implantable device - Google Patents

Protection apparatus for patient-implantable device Download PDF

Info

Publication number
EP0228539B1
EP0228539B1 EP19860115444 EP86115444A EP0228539B1 EP 0228539 B1 EP0228539 B1 EP 0228539B1 EP 19860115444 EP19860115444 EP 19860115444 EP 86115444 A EP86115444 A EP 86115444A EP 0228539 B1 EP0228539 B1 EP 0228539B1
Authority
EP
European Patent Office
Prior art keywords
means
electrically conductive
current
switch means
impedance path
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP19860115444
Other languages
German (de)
French (fr)
Other versions
EP0228539A1 (en
Inventor
William Leon Winstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intermedics Inc
Original Assignee
Intermedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US06/799,804 priority Critical patent/US4745923A/en
Priority to US799804 priority
Application filed by Intermedics Inc filed Critical Intermedics Inc
Publication of EP0228539A1 publication Critical patent/EP0228539A1/en
Application granted granted Critical
Publication of EP0228539B1 publication Critical patent/EP0228539B1/en
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/37Monitoring; Protecting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/37Monitoring; Protecting
    • A61N1/3718Monitoring of or protection against external electromagnetic fields or currents
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02HEMERGENCY PROTECTIVE CIRCUIT ARRANGEMENTS
    • H02H9/00Emergency protective circuit arrangements for limiting excess current or voltage without disconnection
    • H02H9/02Emergency protective circuit arrangements for limiting excess current or voltage without disconnection responsive to excess current
    • H02H9/025Current limitation using field effect transistors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/908Patient protection from electric shock

Description

    BACKGROUND OF THE INVENTION
  • The invention disclosed herein relates generally to protection devices used to protect other devices from damage or destruction resulting from voltage or current surges. In particular, the present invention relates to such a protection device which is implantable in the body of a patient with a heart pacemaker to protect the pacemaker against current surges, particularly those resulting from the operation of an external or implanted heart defibrillator.
  • It is well known that in many instances an implanted heart pacemaker can successfully regulate the otherwise faulty operation of a damaged or diseased heart. Generally, a typical pacemaker senses electrical activity or lack of such activity in the heart muscle, and supplies electrical stimulus pulses to the heart to stimulate contractions when necessary. The electrical stimulus pulses generated by a pacemaker, however, are ineffective to stop the lethal condition of fibrillation. However, it is well known that the application of a series of high-voltage pulses to the heart is often effective in arresting fibrillation. Of course it is desirable following defibrillation of the heart for the pacemaker to resume its normal regulatory role. A serious problem in this regard, however, is that without adequate protection against the large current flow induced by the application of high-voltage defibrillation pulses to the heart, a pacemaker can be damaged or destroyed. Obviously, from the standpoint of the patient's continued well being, this is a totally unacceptable consequence.
  • In the past, a number of attempts have been made to provide adequate protection against excessive currents and voltages for pacemakers and other medical devices such as electrocardiogram (ECG) amplifiers. For example, it is known to connect one or more zener diodes between the opposite leads of a pacemaker to limit the voltage differential therebetween.
  • However, as discussed in U.S. Patent No. 4,320,763 to Money, this approach is not effective to limit the current flow between the heart tissue and the electrode at the distal end of the pacemaker lead. As a result, the heart tissue near the point of contact with the electrode can be severely damaged when high-voltage defibrillation pulses are applied to the heart. The '763 patent discloses that such tissue damage can be prevented by connecting a current limiting device such as a diode or a pair of field effect transistors (FETs) in series between a pacemaker output terminal and a distal electrode. However, it is apparent that the current limiting device thereby becomes a permanent part of the pacemaker circuit. When current limiting is not needed, for example during normal pacing operation, it is desirable to remove the current limiting device from the circuit to avoid unnecessary noise generation as well as loading effects.
  • An approach for protecting the pacemaker circuitry itself is disclosed in U.S.. Patent No. 4,440,172 to Langer. The '172 patent discloses an implantable pacemaker and defibrillator unit in which the pacemaker and defibrillator share common output and return lines. The pacemaker generates negative-going stimulus pulses and is protected against the positive-going high-voltage defibrillator pulses by a resistor and forward biased diode connected in series between the common output line and ground. This approach only provides limited protection to the pacemaker from unidirectional defibrillation pulses. Recent medical research has shown, however, that a number of benefits are obtained by using a bidirectional or "biphasic" pulse train to defi- brillate the heart. Some of the benefits of "biphasic" defibrillation, which forms no part of the present invention, are discussed in Schuder, Defibrillation of 100ka Calves With Asvmmetrical. Bidirectional. Rectangular Pulses. Cardiovascular Research 419-426 (1984), and Jones, Decreased Defibrillator-Induced Dysfunction With Biphasic Rectangular Waveforms, Am. J. Physiol. 247 (Heart Circ. Physiol. 16): H792-H796 (1984).
  • U.S. Patent No. 3,886,932 to Suessmilch discloses an approach in which a small sampling resistor is connected in series with a pacemaker lead. The resistor voltage is compared to a preselected reference voltage. If the resistor voltage exceeds the reference voltage, a switch in series with the resistor and lead is opened for a preselected period of time, after which it is closed and the voltage across the resistor again sampled. With this approach, there is no way to know what the current in the pacemaker lead will be when the switch closes at the end of the preselected time period. As a result, when the switch closes, it is possible that a current flow in the lead will rise very rapidly. Even if the switch is quickly opened again, a current spike of unknown magnitude can be transmitted to the pacemaker, possibly causing damage, or causing the pacemaker sensor circuitry to misinterpret the status of the heart.
  • U.S. Patent No. 4,102,348 to Hihara discloses an approach similar to that of Suessmilch except that the series switch is implemented as a bipolar transistor, the base voltage of which is supplied by the signal on the pacemaker lead through a resistive voltage divider. The state of the switch depends on the voltage of the signal on the lead. This approach, similarly to the Langer patent provides protection only against unidirectional defibrillation pulses.
  • Accordingly, the present invention has as an object to provide a protection device that protects both a pacemaker or other implantable device and the heart tissue near a lead thereof against damage from high current and voltage levels, particularly those induced by the application of defibrillation pulses. In addition, the present invention had as an object to provide a protection device that switches into the circuit of a pacemaker or other implantable device to limit current in a lead of the device when current exceeds a safe limit, but which is effectively switched out of the circuit during normal operation of the device. Another object of the present invention is to provide a protection device that provides protection against high-voltage bidirectional or "biphasic" defibrillation pulses. Still another object of the present invention is to provide a protection device that prevents the transmission of possibly dangerous current and voltage spikes to the pacemaker or other device.
  • SUMMARY OF THE INVENTION
  • The above objects and advantages of the present invention are achieved by providing apparatus according to claims 1 and 9. The sensor senses the current flowing in at least one of the leads of the electrical device being protected, and generates a signal representative of the current. The controller responds to the signal and causes the switching unit to open the electrically conductive low-impedance path established by the lead when the current flowing in the lead exceeds a safe amplitude. When the electrically conductive low-impedance path is open, current is forced to flow in the electrically conductive high-impedance path where it is limited to a safe amplitude.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • An exemplary illustration of a presently preferred embodiment of the present invention is shown in the accompanying drawings, in which:
    • FIG. 1 is a block diagram illustrating a protection circuit comprising a presently preferred embodiment of the present invention in conjunction with a heart pacemaker and defibrillator unit;
    • FIG. 2 is a schematic diagram of a protection circuit comprising a presently preferred embodiment of the present invention;
    • FIG. 3 is a graph of voltage vs. time illustrating a typical biphasic defibrillation pulse train; and
    • FIG. 4 is a graph of current vs. time synchronized with the graph of FIG. 3 and illustrating the current typically produced in a pacemaker lead by the pulse train of FIG. 4 with the protection circuit comprising a presently preferred embodiment of the present invention arranged as shown in FIGS. 1 and 2.
    DETAILED DESCRIPTION OF A PRESENTLY PREFERRED EMBODIMENT
  • The novel features believed to be characteristic of the present invention are set forth in the appended claims. The invention itself, together with further objects and attendant advantages, will best be understood by reference to the following detailed description, which, when taken in conjunction with the accompanying drawings, discloses a presently preferred embodiment of the invention.
  • Referring to FIG. 1, a heart pacemaker 10 implanted in the body of a patient is electrically connected in circuit with the patient's heart 11 via conventional electrically conductive pacing/sensing and return leads 12,13. Pacing/sensing lead 12 contains an electrically conductive barbed or screw-shaped pacing/sensing electrode 14 at its distal end for making firm electrical contact with the heart 11. Return lead 13 contains at its distal end a conductive patch 15 which may be sewn to the wall of the heart 11 to ensure a solid electrical connection. Electrically connected between the pacing/sensing and return leads 12,13 are first and second zener diodes 17,18 arranged back to back to limit the voltage differential between the terminals of the pacemaker 10. First zener diode 17 preferably limits the positive voltage differential to approximately +3V. Second zener diode 18 preferably limits the negative differential to approximately -10V. A protection circuit 16 comprising a presently preferred embodiment of the present invention is implanted with the pacemaker 10 and is electrically connected in series with return lead 13 and patch 15 between the heart 11 and the pacemaker 10.
  • In addition, a defibrillator 117, which may be either an external or an implanted unit, is also electrically connected in circuit with the heart 11. If implanted, the defibrillator 117 is electrically connected to the heart 11 via conventional electrically conductive output and return leads 19,21. Output lead 19 had attached to its distal end a conductive patch 20 which may be sewn to the wall of the heart 11. In this embodiment, return lead 21 is electrically connected at its distal end by any suitable means to return lead 13 between the heart 11 and the protection circuit 16 so that the pacemaker 10 and the defibrillator 17 share a common return lead to some extent. Of course, if the defibrillator 17 is an external unit, then no direct connections to the heart 11 are present. Instead, electrically conductive paddles of a type well known to those skilled in the art are applied externally to the chest of a patient in the vicinity of the heart 11 as output and return electrodes.
  • It is understood that the pacemaker 10 and defibrillator 17 described above are exemplary devices only and that the protection circuit 16 comprising a presently preferred embodiment of the present invention will find use in many other applications where protection of a device against high voltages and currents is desirable.
  • As illustrated in Fig. 2, the protection circuit 16 is electrically connected to conductive patch 15 via return lead 13. In series with return lead 13 are a first and a second field effect transistor (FET) 22, 23 and a 5 ohm sensing resistor 24. The drain of the second FET 23 connects to return lead 13 on the heart 11 side. The source of the second FET 23 connects to one end of the sensing resistor 24 and the source of the first FET 22 connects to the opposite end. The drain of the first FET 16 connects to the opposite end of return lead 13 on the pacemaker 10 side. The gates of the first and second FETs 22,23 are connected in parallel to one end of a 390K ohm current limiting resistor 29 and to the collectors of first and second parallel bipolar transistors 25,26. The other end of the 390K ohm current limiting resistor 29 connects to a DC voltage source 30.
  • The emitter of the first bipolar transistor 25 connects to the source of the first FET 22. The emitter of the second bipolar transistor 26 connects to the source of the second FET 23. A first 1K ohm resistor 27 connects the base of the first bipolar transistor 25 with the emitter of the second bipolar transistor 26. Likewise, a second 1 k ohm resistor 28 connects the base of the second bipolar transistor with the emitter of the first bipolar transistor 25. The base of the first bipolar transistor 25 also connects to the drain of the second FET 23 through a first 82K ohm resistor 32. Likewise, the base of the second bipolar transistor 26 connects to the drain of the first FET 22 through a second 82K ohm resistor 31.
  • The DC voltage source 30 is preferably derived by a conventional voltage multiplication technique, for example employing switched capacitors, and a miniature long-life battery such as a lithium cell to obtain an output of 8-9VDC. The first and second FETs 22,23 are preferably n-channel FETs and are preferably able to withstand voltages in the 1000 volt range, as well as substantial continuous and peak currents. Also, the first and second FETs 22,23 preferably exhibit very fast turn-off times and good conduction at a relatively low threshold voltage. Further, the FET's are preferably of the type in which the source is internally connected to the substrate. Commercially available Motorola MTM-IN100 n-channel FETs and equivalents, for example, have been found to possess the desired characteristics, and are suitable for use. First and second bipolar transistors 21,22 are preferably conventional, commercially available NPN transistors such as, for example, 2N2222A transistors. The 5 ohm sensing resistor may be any suitable precision resistor.
  • It should be apparent to those skilled in the art that although the foregoing describes a presently preferred embodiment of the present invention in terms of a positive DC voltage source, n-channel FETs, and NPN bipolar transistors, a protection circuit employing a negative DC voltage source, p-channel FETs, and PNP bipolar transistors constitutes an equally preferred embodiment.
  • Operation of the protection circuit 16 of FIG. 2 will now be described. In the normal pacing/sensing mode, the pacing/sensing lead 12 and pacing/sensing electrode 14 conduct electrical signals generated by the heart 11 to the pacemaker 10. If the pacemaker 10 fails to detect electrical activity in the heart, it generates one or more electrical stimulus pulses 135. A typical stimulus pulse 135 might be, for example, a short duration, rectangular -8V pulse. The pacing/sensing lead 12 and the pacing/sensing electrode 14 conduct these stimulus pulses 135 to the heart 11 to hopefully stimulate cardial activity. In the normal pacing/sensing mode, current in the pacing/sensing and return leads 12,13 typically ranges from approximately .1 to 35 milliamperes. The gates of the first and second FETs 22,23 are held at a positive voltage in excess of the conduction threshold by the DC voltage source 30. The potential at the sources of the first and second FETs 22,23 is substantially lower than at the gates and the first and second FETs conduct current like closed switches with very little impedance. Assuming the current in the return lead 13 is, as stated above, no more than about ±35 milliamperes, the voltage drop across the 5 ohm sensing resistor 24 is insufficient to forward bias the base-emitter junction of either the first or the second bipolar transistor 25,26 so that neither transistor is conductive. Thus, in the normal pacing/sensing mode, current continues to flow through the low impedance path established by the return lead 13, the 5 ohm sensing resistor 24, and the first and second FETs 22,23. The high-impedance portion of the protection circuit 16 comprising the 82K ohm and 1 K ohm resistors 27, 28, 31, 32 is effectively switched out of the circuit.
  • However, when the heart 11 begins to fibrillate, the condition is sensed by the defibrillator 117 or other monitoring equipment. In response, the defibrillator 117 generates a series of high-voltage pulses which are conducted to the heart 11 via lead 20 or an external paddle. Fig. 3 illustrates a typical biphasic defibrillation pulse train which has been found to be particularly efficacious in arresting defibrillation, and which in addition has been found to impart beneficial post-defibrillation healing effects to the heart. The biphasic pulse train itself forms no part of the present invention but is included herein for the purpose of illustrating various features of the present invention.
  • The typical biphasic defibrillation pulse train may consist of an initial positive pulse 33 rising to a peak of approximately 400 volts in approximately 50 microseconds, having an on-time of 2-5 milliseconds, and a turn off time of approximately 10 microseconds. A second negative pulse 34 of greater magnitude typically follows the initial positive pulse 33. The second negative pulse 34 may rise to a peak of approximately -800 volts in approximately 50 microseconds, have an on-time of 5-8 milliseconds, and a turn-off time of approximately 10 microseconds. In some instances, a final positive pulse 35 has been found to impart beneficial healing effects to the defibrillated heart. The final positive high-voltage pulse 35 may rise to a peak voltage of approximately 300 volts in approximately 50 microseconds, have an on-time of 2-5 milliseconds, and a turn-off time of approximately 10 microseconds.
  • When the initial positive pulse 33 is applied to the heart 11, the positive potential at the conductive patch 15 raises rapidly. As illustrated in FIG. 4, this in turn causes the positive current in return lead 13 to rise rapidly, in turn causing the positive voltage drop across the 5 ohm sensing resistor 24 to rise rapidly. When the amplitude of the positive current flow through the sensing resistor 24 reaches approximately .12 amperes resulting in a voltage drop across the sensing resistor 24 of approximately .6 volts, the base-emitter junction of the first bipolar transistor 25 becomes forward biased. The first bipolar transistor 25 then becomes conductive and electrically connects the sources and gates of the first and second FETs 22,23. This in turn causes the conduction channels between the sources and drains of the first and second FETs 22,23 to collapse. However, because each of the FETs has its source and substrate permanently connected internally, at high currents each acts as a diode forward biased between the source and drain. Thus, the second FET 23 acts as a reverse biased diode or open switch to the positive current in return lead 13 while the first FET 22 acts as a forward biased diode to the positive current. As a result, when the normal conduction paths of the first and second FETs 22,23 collapse, the high-impedance portion of the protection circuit 16 is switched in and an alternate high-impedance conduction path in series with the return lead 13 is established. This path comprises the 82K ohm resistor 32, the 1 K ohm resistor 25, the 5 ohm sensing resistor 24, and the first FET 22. The switching of the high-impedance conduction path results in a sharp drop 36 in current to a safe maximum current 36a of approximately 4-5 milliamperes.
  • The first bipolar transistor 25 remains conductive until the positive voltage at the conductive patch 15 drops below approximately 50 volts. At this point, the current flowing in the high-impedance conduction path is insufficient to forward bias the base-emitter junction of the first bipolar transistor 25, which ceases to conduct. This in turn disconnects the sources and gates of the first and second FETs 22,23, which re-establishes the source to drain conduction channels and allows the FETs 22,23 to once again conduct as closed switches. Because the positive potential at the conductive patch 15 is still approximately 50 volts at this time, a small current surge 37 having a peak magnitude substantially less than the maximum safe amplitude of approximately .12 amperes occurs.
  • When the second negative biphasic pulse 34 is applied to the heart 11, the magnitude of the negative potential at the conductive patch 15 increases rapidly. In turn, the magnitude of the negative current flowing through and the voltage across the 5 ohm sensing resistor 24 also increase rapidly. When the magnitude of the negative current reaches approximately -.12 amperes with a corresponding voltage drop of -.6 volts across the 5 ohm sensing resistor 24, the base-emitter junction of the second bipolar transistor 26 becomes forward biased. The second bipolar transistor 26 then becomes conductive and electrically connects the sources and gates of the first and second FETs 22,23. This in turn causes the source to drain conduction paths in the FETs 22,23 to collapse. In this case, the first FET 22 acts as a reverse biased diode or open switch to the negative current while the second FET 23 acts as a forward biased diode. As a result, the high-impedance portion of the protection circuit 16 is switched in and an alternate high-impedance conduction path for the negative current is established. This path comprises the 82K ohm resistor 31, the 1 K ohm resistor 28, the 5 ohm sensing resistor 24, and the second FET 23. The 82K ohm resistor 31, the 1K ohm resistor 28, the 5 ohm sensing resistor 24, the collector- emitter path of the second bipolar transistor 26, and the 390K ohm resistor 29 establish a parallel high-impedance path for the negative current. The switching in of the parallel high-impedance conduction paths results in a sharp decline 38 in the current of the negative current to a safe maximum amplitude 38a of less than 10 milliamperes as illustrated in Fig. 4.
  • The second bipolar transistor 26 remains conductive until the magnitude of the negative potential at the conductive patch 15 drops to approximately -50 volts. At this point, the negative current flowing in the parallel, high-impedance paths is insufficient to forward bias the base-emitter junction of the second bipolar transistor 26, which ceases to conduct. This in turn disconnects the sources and gates of the first and second FETs 25,26, which re-establishes the source to drain conduction channels and causes the FETs 25,26 to again conduct as closed switches. Because the negative potential at the conductive patch 15 is still approximately -50 volts at this time, a small negative current surge 39 having a peak magnitude substantially less than the maximum safe amplitude of approximately -.12 amperes occurs.
  • Operation of the protection circuit 16 for subsequent positive and negative defibrillation pulses including pulse 35 of Fig. 3 is identical. In addition, the presently preferred embodiment of the protection circuit 16 operates the same regardless of whether the defibrillator pulses are directly applied to the heart 11 as illustrated in Fig. 1, or are applied externally via conductive paddles as described above. Operation of the presently preferred embodiment of the protection circuit is also independent of the manner of pacing and sensing employed.

Claims (16)

1. An apparatus (16) for protecting an implantable electrical device having a plurality of electrically conductive leads against excessive currents and voltages on said leads, comprising
means (24) for sensing the current flowing in at least one of said leads, and for generating a signal representative of that current;
switch means (22, 24) for opening and closing an electrically conductive low-impedance path established at least partially by said at least one of said leads;
means (25, 26) responsive to said signal representative of said current for controlling said switch means to open said electrically conductive low-impedance path when said current exceeds a predetermined level; and characterised by
means (32) for establishing at least one alternate, electrically conductive high-impedance path in which said current flows when said electrically conductive low-impedance path is open, whereby the current flowing into said electrical device is limited to a safe level.
2. The apparatus of Claim 1 further comprising means for limiting the maximum voltage between the output and return terminals of said electrical device to a predetermined safe level.
3. The apparatus of Claim 1 wherein said means for sensing said current and for generating a signal representative thereof comprises a sensing resistor.
4. The apparatus of Claim 1 wherein said switch means comprises first switch means for opening said electrically conductive low-impedance path when said signal representative of said current exceeds a first predetermined positive amplitude, and second switch means for opening said electrically conductive low-impedance path when said signal representative of said current exceeds a second predetermined negative amplitude.
5. The apparatus of Claim 1 wherein said switch means and said means for sensing current are in electrical series with said electrically conductive low-impedance path established at least partially by said at least one of said leads.
6. The apparatus of Claim 4 wherein said means for controlling said switch means comprises first control means for controlling said first switch means to open said first switch means when said current exceeds a predetermined positive amplitude, and second control means for controlling said second switch means to open said second switch means when said current exceeds a predetermined negative amplitude.
7. The apparatus of Claim 6 wherein:
said first switch means comprises a first field effect transistor and said second switch means comprises a second field effect transistor;
said first control means comprises a first transistor arranged to electrically connect the gates and sources of said first and second field effect transistors when said current exceeds a predetermined positive amplitude; and
said second control means comprises a second transistor arranged to electrically connect the gates and sources of said first and second field effect transistors when said current exceeds a predetermined negative amplitude.
8. The apparatus of Claim 4 wherein said first means for opening said electrically conductive low-impedance path forms part of said alternate, electrically conductive high-impedance path when said current exceeds a predetermined positive amplitude, and wherein said second means for opening said electrically conductive path forms part of said alternate, electrically conductive high-impedance path when said current exceeds a predetermined negative amplitude.
9. A patient implantable apparatus for assisting the proper functioning of the patient's heart, comprising:
pacemaker (10 means for receiving signals representative of the activity of the patient's heart and for transmitting electrical stimulus signals to the heart to stimulate activity;
a plurality of electrically conductive low-impedance leads (12, 13) connected to the patients's heart, and to the pacemaker means for communicating said electrical signals representative of the activity of the heart to the pacemaker means, and for communicating said electrical stimulus signals from said pacemaker means to the heart; and
means (16) for protecting said. pacer means against damage from excessive currents and voltages on said plurality of leads comprising:
means (24) for sensing the current flowing in at least one of said leads, and for generating a signal representative of that current;
switch means (22, 23) for opening and closing an electrically conductive low-impedance path established at least partially by said at least one of said leads;
means (25, 26) responsive to said signal representative of said current for controlling said switch means to open said electrically conductive low-impedance path when said current exceeds a predetermined level; and characterised by
means (32) for establishing an alternate, electrically conductive high-impedance path in which said current flows when said electrically conductive low-impedance path is open, whereby the current flowing into said pacemaker means is limited to a safe level.
10. The apparatus of Claim 9 comprising means for limiting the maximum voltage between the terminals of said pacemaker means to a predetermined safe level.
11. The apparatus of Claim 9 wherein said means for sensing said current and for generating a signal representative thereof comprises a sensing resistor.
12. The apparatus of Claim 9 wherein said switch means comprises first switch means for opening said electrically conductive low-impedance path when said signal representative of said current exceeds a first predetermined positive amplitude, and second switch means for opening said electrically conductive low-impedance path when said signal representative of said current exceeds a second predetermined negative amplitude.
13. The apparatus of Claim 9 wherein said switch means and said means for sensing current are in electrical series with said electrically conductive low-impedance path established at least partially by said at least one of said leads.
14. The apparatus of Claim 12 wherein said means for controlling said switch means comprises first control means for controlling said first switch means to open said first switch means when said current exceeds a predetermined positive amplitude, and second control means for controlling said second switch means to open said second switch means when said current exceeds a predetermined negative amplitude.
15. The apparatus of Claim 13 wherein:
said first switch means comprises a first field effect transistor and said second switch means comprises a second field effect transistor;
said first control means comprises a first transistor arranged to electrically connect the gates and sources of said first and second field effect transistors when said current exceeds a predetermined positive amplitude; and
said second control means comprises a second transistor arranged to electrically connect the gates and sources of said first and second field effect transistors when said current exceeds a predetermined negative amplitude.
16. The apparatus of Claim 12 wherein said first means for opening said electrically conductive low-impedance path forms part of said alternate, electrically conductive high-impedance path when said current exceeds a predetermined positive amplitude, and wherein said second means for opening said electrically conductive low-impedance path forms part of said alternate, electrically conductive high-impedance path when said current exceeds a predetermined negative amplitude.
EP19860115444 1985-11-20 1986-11-07 Protection apparatus for patient-implantable device Expired - Lifetime EP0228539B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US06/799,804 US4745923A (en) 1985-11-20 1985-11-20 Protection apparatus for patient-implantable device
US799804 1985-11-20

Publications (2)

Publication Number Publication Date
EP0228539A1 EP0228539A1 (en) 1987-07-15
EP0228539B1 true EP0228539B1 (en) 1990-04-11

Family

ID=25176794

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19860115444 Expired - Lifetime EP0228539B1 (en) 1985-11-20 1986-11-07 Protection apparatus for patient-implantable device

Country Status (5)

Country Link
US (1) US4745923A (en)
EP (1) EP0228539B1 (en)
JP (1) JPH0651067B2 (en)
CA (1) CA1290024C (en)
DE (1) DE3670209D1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010051486A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
WO2010062463A1 (en) * 2008-10-31 2010-06-03 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US8498698B2 (en) 2008-10-31 2013-07-30 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US8560060B2 (en) 2008-10-31 2013-10-15 Medtronic, Inc. Isolation of sensing and stimulation circuitry

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4796630A (en) * 1987-03-23 1989-01-10 Telectronics N.V. Cardiac pacemaker with combined defibrillation and electrosurgery protection
US4949720A (en) * 1988-09-20 1990-08-21 Medtronic, Inc. Apparatus for measuring the lead current in a pacemaker
GB2234908B (en) * 1989-08-16 1993-08-11 Cardiac Pacemakers Inc Combined defibrillator-pacer system utilising pacer tip lead switch
EP0426969A3 (en) * 1989-11-10 1992-10-28 Lewicki Microelectronic Gmbh Protecting circuit
US5163428A (en) * 1990-10-11 1992-11-17 Ventritex, Inc. Implantable cardiac defibrillator with current leakage detecting means
US5285780A (en) * 1990-11-29 1994-02-15 Nippon Zeon Co., Ltd. Pacemaker with improved pulse detection
DE59209886D1 (en) * 1992-05-12 2001-02-15 Pacesetter Ab Jaerfaella implantable defibrillation
US5325870A (en) * 1992-12-16 1994-07-05 Angeion Corporation Multiplexed defibrillation electrode apparatus
US5879374A (en) * 1993-05-18 1999-03-09 Heartstream, Inc. External defibrillator with automatic self-testing prior to use
US5601612A (en) * 1993-08-06 1997-02-11 Heartstream, Inc. Method for applying a multiphasic waveform
US5607454A (en) * 1993-08-06 1997-03-04 Heartstream, Inc. Electrotherapy method and apparatus
FR2708860B1 (en) * 1993-08-11 1995-10-13 Ela Medical Sa Protective circuit for an implantable electronic device.
DE69424101T2 (en) * 1993-08-11 2000-09-21 Ela Medical Sa Protection circuit for an electronic device einpflanzbares
AU3299995A (en) 1994-10-04 1996-04-18 Medtronic, Inc. Protective feedthrough
US5735884A (en) * 1994-10-04 1998-04-07 Medtronic, Inc. Filtered feedthrough assembly for implantable medical device
US5556420A (en) * 1994-12-29 1996-09-17 Pacesetter, Inc. Input protection circuit for pacemaker activity sensor processing circuitry
FR2728799B1 (en) * 1994-12-30 1997-03-28 Ela Medical Sa active implantable device, in particular pacemaker or defibrillator heart, comprising means for protection against electromagnetic disturbances of external origin
US5620465A (en) * 1995-06-08 1997-04-15 Survivalink Corporation External defibrillator for producing and testing biphasic waveforms
US5761019A (en) * 1996-01-11 1998-06-02 L.Vad Technology, Inc. Medical current limiter
US5817130A (en) * 1996-05-03 1998-10-06 Sulzer Intermedics Inc. Implantable cardiac cardioverter/defibrillator with EMI suppression filter with independent ground connection
US6263239B1 (en) 1996-07-01 2001-07-17 Survivalink Corporation Method and apparatus for determining the second phase of defibrillator devices
US6411846B1 (en) * 1999-08-26 2002-06-25 Survivalink Corporation Method and apparatus for delivering a biphasic defibrillation pulse with variable energy
US5968080A (en) * 1996-07-01 1999-10-19 Survivalink Corporation Method for determining the second phase of external defibrillator devices
US5720767A (en) * 1996-10-02 1998-02-24 Pacesetter, Inc. Impedance dependent implantable cardioverter-defibrillator
US5772692A (en) * 1996-10-29 1998-06-30 Sulzer Intermedics Inc. Implantable medical device with automatic adjustment to externally generated shocks
US6198972B1 (en) * 1997-04-30 2001-03-06 Medtronic, Inc. Control of externally induced current in implantable medical devices
US5899925A (en) * 1997-08-07 1999-05-04 Heartstream, Inc. Method and apparatus for aperiodic self-testing of a defibrillator
US5968083A (en) * 1997-11-12 1999-10-19 Pacesetter, Inc. Active overload detection and protection circuit for implantable cardiac therapy devices
US8600519B2 (en) * 2001-04-13 2013-12-03 Greatbatch Ltd. Transient voltage/current protection system for electronic circuits associated with implanted leads
US6104953A (en) * 1999-01-28 2000-08-15 Heartstream, Inc. Method and apparatus for delivering defibrillation and pacing energy from a single power source
US6119039A (en) 1999-01-28 2000-09-12 Heartstream, Inc. Method and apparatus for delivering defibrillation energy
US6161040A (en) * 1999-02-16 2000-12-12 Pacesetter, Inc. Current limiter for an implantable cardiac device
US6405081B1 (en) 1999-04-22 2002-06-11 Koninklijke Philips Electronics N.V. Damped biphasic energy delivery circuit for a defibrillator
US6230054B1 (en) 1999-04-23 2001-05-08 Agilent Technologies, Inc. Apparatus for controlling delivery of defibrillation energy
EP1259291B1 (en) * 2000-02-18 2003-09-10 Heartsine Technologies Limited A defibrillator
US7130682B2 (en) * 2000-12-26 2006-10-31 Cardiac Pacemakers, Inc. Pacing and sensing vectors
US20100191306A1 (en) * 2006-01-25 2010-07-29 Greatbatch Ltd. Transient voltage suppression circuit for an implanted rfid chip
US7091412B2 (en) 2002-03-04 2006-08-15 Nanoset, Llc Magnetically shielded assembly
US7162302B2 (en) 2002-03-04 2007-01-09 Nanoset Llc Magnetically shielded assembly
US7110815B2 (en) * 2002-05-06 2006-09-19 Cardiac Pacemakers, Inc. System and method for providing temporary stimulation therapy to optimize chronic electrical performance for electrodes used in conjunction with a cardiac rhythm management system
US6864418B2 (en) * 2002-12-18 2005-03-08 Nanoset, Llc Nanomagnetically shielded substrate
DE10323627A1 (en) * 2003-05-20 2004-12-09 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Implantable electrotherapy unit, especially a heart pacemaker or defibrillator that can be linked via a radio interface to a heart pacemaker of defibrillator to permit exchange of control signals between the two units
EP1515441B1 (en) 2003-09-05 2010-01-20 Biotronik GmbH & Co. KG Voltage resistant MOS switch
DE10358048A1 (en) * 2003-09-05 2005-03-31 Biotronik Gmbh & Co. Kg Metal-oxide semiconductor switch for cardiac pacemaker/defibrillator, has switching monitoring unit that produces switching-through potential at protection output when switching transistors are in non-conducting condition
US7526336B2 (en) * 2004-03-05 2009-04-28 Pacesetter, Inc. Left heart implantable cardiac stimulation system with clot prevention and method
US8099174B1 (en) 2004-03-05 2012-01-17 Pacesetter, Inc. Left heart implantable cardiac stimulation system with clot prevention electrode body coating and method
DE102004062399B4 (en) * 2004-12-23 2009-02-05 Siemens Ag Implantable cardiac pacemaker
US7711419B2 (en) 2005-07-13 2010-05-04 Cyberonics, Inc. Neurostimulator with reduced size
US8165693B2 (en) * 2005-07-21 2012-04-24 Cyberonics, Inc. Safe-mode implantable medical devices
US7499752B2 (en) 2005-07-29 2009-03-03 Cyberonics, Inc. Selective nerve stimulation for the treatment of eating disorders
US20070027499A1 (en) * 2005-07-29 2007-02-01 Cyberonics, Inc. Neurostimulation device for treating mood disorders
US7532935B2 (en) 2005-07-29 2009-05-12 Cyberonics, Inc. Selective neurostimulation for treating mood disorders
US7555344B2 (en) 2005-10-28 2009-06-30 Cyberonics, Inc. Selective neurostimulation for treating epilepsy
US7801601B2 (en) * 2006-01-27 2010-09-21 Cyberonics, Inc. Controlling neuromodulation using stimulus modalities
EP1981591B1 (en) 2006-02-01 2017-10-11 Koninklijke Philips N.V. Energy efficient defibrillation current limiter
US7729770B2 (en) * 2006-04-26 2010-06-01 Medtronic, Inc. Isolation circuitry and method for gradient field safety in an implantable medical device
US8049489B2 (en) 2006-07-26 2011-11-01 Cardiac Pacemakers, Inc. Systems and methods for sensing external magnetic fields in implantable medical devices
US8768486B2 (en) * 2006-12-11 2014-07-01 Medtronic, Inc. Medical leads with frequency independent magnetic resonance imaging protection
US7865247B2 (en) * 2006-12-18 2011-01-04 Medtronic, Inc. Medical leads with frequency independent magnetic resonance imaging protection
US20090163980A1 (en) * 2007-12-21 2009-06-25 Greatbatch Ltd. Switch for turning off therapy delivery of an active implantable medical device during mri scans
US20090163981A1 (en) 2007-12-21 2009-06-25 Greatbatch Ltd. Multiplexer for selection of an mri compatible band stop filter or switch placed in series with a particular therapy electrode of an active implantable medical device
DE102008002330A1 (en) * 2008-06-10 2009-12-17 Biotronik Crm Patent Ag Snubber
DE102009041329A1 (en) * 2009-09-15 2011-03-24 Celon Ag Medical Instruments Combined ultrasound and HF surgical system
US9126055B2 (en) 2012-04-20 2015-09-08 Cardiac Science Corporation AED faster time to shock method and device
US9555188B2 (en) * 2012-04-27 2017-01-31 Medtronic, Inc. Implantable infusion device having voltage boost circuit and selection circuit to alternately connect battery with charging circuit
DE102015016091B3 (en) * 2015-12-11 2016-11-17 Drägerwerk AG & Co. KGaA Active protection circuit for a sense amplifier in an electrode belt for an electric lmpedanztomographen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518986A (en) * 1967-11-20 1970-07-07 Beckman Instruments Inc Patient monitoring safety system
US3521087A (en) * 1969-05-16 1970-07-21 Spacelabs Inc Current limiting circuit
US3603811A (en) * 1969-12-09 1971-09-07 American Optical Corp Two-terminal bipolar self-powered low current limiter
DE2340123A1 (en) * 1973-08-08 1975-02-20 Schwarzer Gmbh Fritz Over-current protection circuit
SU612331A1 (en) * 1974-07-09 1978-06-25 Turchenkov Vladimir Limiter of the current passing through the human body at electric current treatment
AT331893B (en) * 1974-10-28 1976-08-25 Siemens Ag Circuit arrangement for monitoring a measurement voltage
FR2298909B1 (en) * 1975-01-24 1981-05-08 Medtronic Inc
US3968802A (en) * 1975-01-24 1976-07-13 Medtronic, Inc. Cautery protection circuit for a heart pacemaker
JPS5745190B2 (en) * 1976-05-19 1982-09-27
US4082097A (en) * 1976-05-20 1978-04-04 Pacesetter Systems Inc. Multimode recharging system for living tissue stimulators
US4320763A (en) * 1979-10-10 1982-03-23 Telectronics Pty. Limited Protection device for pacemaker implantees
US4440172A (en) * 1980-10-02 1984-04-03 Mieczyslaw Mirowski Apparatus for combining pacing and cardioverting functions in a single implanted device
DE3229134C2 (en) * 1982-08-04 1991-11-28 Gs Elektromed. Geraete Guenter Stemple, 8912 Kaufering, De
DE3240280C2 (en) * 1982-10-30 1991-03-14 Robert Bosch Gmbh, 7000 Stuttgart, De
DE3308320A1 (en) * 1983-03-09 1984-09-13 Standard Elektrik Lorenz Ag Circuit arrangement for limiting the inrush
DE3321051A1 (en) * 1983-06-07 1984-12-13 Biotronik Mess & Therapieg Protective circuit for pacemakers
FR2559068B1 (en) * 1984-02-06 1990-01-26 Medtronic Inc protection circuit for an implantable cardiac device restoration

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010051486A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
WO2010062463A1 (en) * 2008-10-31 2010-06-03 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US8473057B2 (en) 2008-10-31 2013-06-25 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
US8498698B2 (en) 2008-10-31 2013-07-30 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US8560060B2 (en) 2008-10-31 2013-10-15 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US9192769B2 (en) 2008-10-31 2015-11-24 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system

Also Published As

Publication number Publication date
US4745923A (en) 1988-05-24
JPH0651067B2 (en) 1994-07-06
CA1290024C (en) 1991-10-01
EP0228539A1 (en) 1987-07-15
DE3670209D1 (en) 1990-05-17
JPS62137070A (en) 1987-06-19

Similar Documents

Publication Publication Date Title
US3563247A (en) Bidirectional heart stimulator
US5643328A (en) Implantable cardiac stimulation device with warning system having elongated stimulation electrode
US5749904A (en) Electrotherapy method utilizing patient dependent electrical parameters
US6834204B2 (en) Method and apparatus for inducing defibrillation in a patient using a T-shock waveform
CA1309468C (en) Cardioverting method and apparatus utilizing catheter and patch electrodes
US5507781A (en) Implantable defibrillator system with capacitor switching circuitry
US4059116A (en) Synchronous pacemaker with upper rate stabilization and method of use
Schuder The role of an engineering oriented medical research group in developing improved methods and devices for achieving ventricular defibrillation: the University of Missouri experience
US3628538A (en) Apparatus for stimulating muscles controlled by the same muscles
CA1123059A (en) Cardiac monitoring apparatus
EP0641573B1 (en) Apparatus for ECG related cardiac defibrillation
EP0808639B1 (en) Patient-worn energy delivery apparatus
US4292968A (en) Electric supply for ion therapy
US5620470A (en) Electrotherapy method
US6169921B1 (en) Autocapture determination for an implantable cardioverter defibrillator
US6778860B2 (en) Switched capacitor defibrillation circuit
AU660845B2 (en) Ring-to-ring cardiac electrogram
CA1120549A (en) Implantable demand pacemaker
US3405715A (en) Implantable electrode
US3915174A (en) Pacing apparatus and improved catheter
US6658294B1 (en) Implantable cardiac device having an impedance monitoring circuit and method
US5067953A (en) Circuit for controlling an electro-therapy device
US4628934A (en) Method and means of electrode selection for pacemaker with multielectrode leads
US7027864B2 (en) Defibrillation system and method designed for rapid attachment
CA1318942C (en) Cardioverting system with high-frequency pulse delivery

Legal Events

Date Code Title Description
AK Designated contracting states:

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI NL

17P Request for examination filed

Effective date: 19871215

17Q First examination report

Effective date: 19890530

AK Designated contracting states:

Kind code of ref document: B1

Designated state(s): CH DE FR GB IT LI NL

REF Corresponds to:

Ref document number: 3670209

Country of ref document: DE

Date of ref document: 19900517

Format of ref document f/p: P

ITF It: translation for a ep patent filed

Owner name: SOCIETA ITALIANA BREVETTI S.P.A.

ET Fr: translation filed
26N No opposition filed
ITTA It: last paid annual fee
PGFP Postgrant: annual fees paid to national office

Ref country code: FR

Payment date: 20001018

Year of fee payment: 15

PGFP Postgrant: annual fees paid to national office

Ref country code: DE

Payment date: 20001019

Year of fee payment: 15

PGFP Postgrant: annual fees paid to national office

Ref country code: CH

Payment date: 20001020

Year of fee payment: 15

Ref country code: GB

Payment date: 20001020

Year of fee payment: 15

PGFP Postgrant: annual fees paid to national office

Ref country code: NL

Payment date: 20001026

Year of fee payment: 15

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011107

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011130

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011130

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020601

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20011107

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020702

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020730

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20020601

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state announced via postgrant inform. from nat. office to epo

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051107